|
|
| P 004292 / Paratek (0 Trials) |
|
| P 1055 / Parion Sciences (0 Trials) |
|
| P 2202 / Eli Lilly, Piramal Phytocare (0 Trials) |
|
| P 979 / Piramal Phytocare (0 Trials) |
|
| P-001 / NB Health Lab (0 Trials) |
|
| P-015 / NB Health Lab (0 Trials) |
|
| P-11187 / Piramal Phytocare (0 Trials) |
|
| P-321 / Parion Sciences (0 Trials) |
|
| P-BCMA-101 / Poseida Therap (2 Trials) |
|
| P-BCMACD19-ALLO1 / Poseida Therap, Roche (0 Trials) |
|
| P-CD19CD20-ALLO1 / Roche (0 Trials) |
|
| P-CD70-ALLO1 / Poseida Therap, Roche (0 Trials) |
|
| P-ckit-ALLO1 / Poseida Therap (0 Trials) |
|
| P-FVIII-101 / Poseida Therap (0 Trials) |
|
| P-MUC1C-101 / Poseida Therap (0 Trials) |
|
| P-MUC1C-ALLO1 / Poseida Therap (0 Trials) |
|
| P-PSMA-101 / Poseida Therap (1 Trials) |
|
| P-PSMA-ALLO1 / Poseida Therap (0 Trials) |
|
| P-selectin glycoprotein ligand (PGSL) and Human IgG1 (YSPSL) / Y's Therap (0 Trials) |
|
| P. gingivalis/POD OH-CRC / CSL Behring (0 Trials) |
|
| p.DOM-WT1-126 DNA vaccine / Inovio (0 Trials) |
|
| P005 / NB Health Lab (0 Trials) |
|
| P007 / NB Health Lab (0 Trials) |
|
| P013 / NB Health Lab (0 Trials) |
|
| P013 (pertuzumab biosimilar) / CinnaGen (0 Trials) |
|
| P11 / Protheragen (0 Trials) |
|
| P1201-07 / Piramal Phytocare (0 Trials) |
|
| P1736 / Piramal Phytocare (0 Trials) |
|
| P2-003 / Luye Group (0 Trials) |
|
| P2-004 / Luye Group (0 Trials) |
|
| P218 / Medicines for Malaria Venture (0 Trials) |
|
| P22077 / Progenra (0 Trials) |
|
| P23H RHO / Precision BioSci (0 Trials) |
|
| P2745 / Piramal Phytocare (0 Trials) |
|
| P2B002 / Pharma Two B (0 Trials) |
|
| P2B003 / Pharma Two B (0 Trials) |
|
| P2X4 Antagonist / Bayer (0 Trials) |
|
| P30-EPS / Duke University, National Cancer Institute (0 Trials) |
|
| P300-CBP transcription factor inhibitor / Acylin Therap (0 Trials) |
|
| P306 / Fox Chase Cancer Center (0 Trials) |
|
| P5091 / Progenra (0 Trials) |
|
| p53/KRAS/EGFR targeted NK cell therapy / Athenex (0 Trials) |
|
| p53MVA / Tara I-O (2 Trials) |
|
| P7435 / Piramal Phytocare (0 Trials) |
|
| P75NEURO / Protheragen (0 Trials) |
|
| P9R / University of Hong Kong (0 Trials) |
|
| PA1010 / Palo Alto Pharma (0 Trials) |
|
| PA83-FhCMB / iBio (0 Trials) |
|
| PAb001-ADC / Peptron (0 Trials) |
|
| PAb001-Car-T / Peptron (0 Trials) |
|
| Pabparna (BB-301) / Benitec BioPharma (0 Trials) |
|
| PAC-1 / Vanquish Oncology (2 Trials) |
|
| PAC-MAN / Stanford University, DNARx (0 Trials) |
|
| pacanalotamab (AMG 420) / Amgen (1 Trials) |
|
| Pacis (bladder cancer vaccine) / GSK (0 Trials) |
|
| Paclical (micellar paclitaxel) / Vivesto, HLB Bio Group (0 Trials) |
|
| paclitaxel / Generic mfg. (1352 Trials) |
|
| paclitaxel (QR 207) / Qrono (0 Trials) |
|
| paclitaxel micelle formulation (NK-105) / NANO MRNA, Nippon Kayaku (0 Trials) |
|
| paclitaxel submicron particle (SOR007) / DFB Pharma, NanOlogy (0 Trials) |
|
| paclitaxel sustained release (PTM-101) / PanTher (0 Trials) |
|
| paclitaxel trevatide (ANG1005) / Angiochem (2 Trials) |
|
| paclitaxel+novel excipient (TYN-21) / BW Therap (0 Trials) |
|
| paclitaxel/NLPD (SG102) / SevenGenes (0 Trials) |
|
| pacmilimab (CX-072) / CytomX (2 Trials) |
|
| PACTN / PersImmune (0 Trials) |
|
| Padcev (enfortumab vedotin-ejfv) / Astellas, Pfizer (38 Trials) |
|
| PADciclo (ciclosporin ophthalmic) / MC2 Therap, Moorfields Eye Hospital (0 Trials) |
|
| padnarsertib (KPT-9274) / Karyopharm (2 Trials) |
|
| padsevonil (UCB0942) / UCB (0 Trials) |
|
| palazestrant (OP-1250) / Olema Pharma (0 Trials) |
|
| Palexia RP (tapentadol extended release) / Assertio, J&J, Grunenthal, Collegium Pharma (4 Trials) |
|
| Palforzia (peanut (Arachis hypogaea) allergen powder-dnfp) / Nestle (6 Trials) |
|
| PALI-2108 / Palisade Bio (0 Trials) |
|
| paliperidone depot injection / Mapi Pharma (0 Trials) |
|
| paliperidone extended release / Generic mfg. (5 Trials) |
|
| paliperidone palmitate ER (LY03010) / Luye Group (0 Trials) |
|
| Paliperidone-ISM (paliperidone in situ microparticle) / ROVI Pharmaceuticals Laboratories (0 Trials) |
|
| palivizumab biosimilar / BioXpress Therap (0 Trials) |
|
| palivizumab biosimilar / iBio (0 Trials) |
|
| palivizumab biosimilar / Utrecht Centre of Excellence for Affordable Biotherapeutics (0 Trials) |
|
| palivizumab biosimilar / NeuClone, Serum Institute of India (0 Trials) |
|
| palmatine / LKT Labs (0 Trials) |
|
| palonosetron intravenous / Generic mfg. (11 Trials) |
|
| paltusotine (CRN00808) / Crinetics (0 Trials) |
|
| palucorcel (CNTO 2476) / J&J (0 Trials) |
|
| Paludrine (proguanil) / Alliance (1 Trials) |
|
| palupiprant (AN0025) / Eisai, Adlai Nortye (2 Trials) |
|
| Palynziq (pegvaliase-pqpz) / BioMarin (2 Trials) |
|
| Pam2CSK4/ODN-M362 / Pulmotect (0 Trials) |
|
| pamapimod (RO4402257) / Roche (1 Trials) |
|
| pamapimod/pioglitazone (KIN001) / Kinarus (0 Trials) |
|
| pamidronate disodium / Generic mfg. (5 Trials) |
|
| pamrevlumab (FG-3019) / FibroGen (2 Trials) |
|
| pamufetinib (TAS-115) / Otsuka (1 Trials) |
|
| PAN-90806 / PanOptica (0 Trials) |
|
| PAN004 / Pantherna Therap (0 Trials) |
|
| PAN006 / Pantherna Therap (0 Trials) |
|
| PAN007 / Pantherna Therap (0 Trials) |
|
| Panaecin (gallium citrate) / Aridis (0 Trials) |
|
| Panaphix (sodium metaarsenite) / Komipharm (0 Trials) |
|
| Panblok (influenza vaccine) / Sanofi (0 Trials) |
|
| Panblok H7/MF59 influenza vaccine / Sanofi (0 Trials) |
|
| PanChol (live attenuated oral cholera vaccine) / Brigham and Womens Hospital (0 Trials) |
|
| pancreatic cancer vaccine / CPL Biologicals, Novavax (0 Trials) |
|
| pancrelipase (NMK-150) / AbbVie (0 Trials) |
|
| PanCytoVir (probenecid) / TrippBio (0 Trials) |
|
| PANDA-VAC / UNC Lineberger Comprehensive Cancer Center (0 Trials) |
|
| Pandel (hydrocortisone probutate) / Novartis (0 Trials) |
|
| Pandemic influenza vaccine H5N1 AstraZeneca (pandemic influenza vaccine (H5N1) (live attenuated, nasal)) / AstraZeneca (0 Trials) |
|
| Pandemic Influenza Vaccine H5N1 Baxter AG (pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture)) / Baxter Healthcare (0 Trials) |
|
| Pandyflu (inactivated H1N1 split virion vaccine) / Panacea Biotec (0 Trials) |
|
| Panenza (influenza A (H1N1) 2009 monovalent vaccine) / Sanofi (0 Trials) |
|
| PanFlu (influenza H5N1 vaccine) / Sinovac (0 Trials) |
|
| PANFLU.1 (influenza A H1N1 influenza virus split vaccine) / Sinovac (0 Trials) |
|
| Panglobulin NF (intravenous normal human immunoglobulin) / CSL Behring (0 Trials) |
|
| Panhematin (hemin) / Lundbeck, Recordati (1 Trials) |
|
| PANHPVAX / German Cancer Research Center (0 Trials) |
|
| PankoMab-GEX (gatipotuzumab) / Glycotope (0 Trials) |
|
| panobinostat (MTX110) / Biodexa Pharma (3 Trials) |
|
| PanOxyl PM Overnight Spot Patches (benzoyl peroxide) / Crown Labs (0 Trials) |
|
| Panretin (alitretinoin topical) / Eisai (0 Trials) |
|
| Panrvlysin (genetically engineered oncolytic virus therapy) / CZ BioMed (0 Trials) |
|
| pantoprazole / Generic mfg. (29 Trials) |
|
| panulisib (P7170) / Piramal Phytocare (0 Trials) |
|
| Panvac-VF (falimarev/inalimarev) / Bavarian Nordic (4 Trials) |
|
| Panvax (influenza A (H1N1) 2009 monovalent vaccine) / CSL Behring (0 Trials) |
|
| Panzem (2-methoxyestradiol) / CASI (0 Trials) |
|
| Panzyga (human immune globulin intravenous 10% stabilised with glycine) / Octapharma (2 Trials) |
|
| PAP CAR-T / Innovative Cellular Therapeutics (0 Trials) |
|
| papaverine / Generic mfg. (0 Trials) |
|
| papiliximab / Shaperon (0 Trials) |
|
| Papitrol (tirvalimogene teraplasmid) / Genexine, National OncoVenture (2 Trials) |
|
| paquinimod (ABR-215757) / Active Biotech (0 Trials) |
|
| PAR-2 / Sawai Pharma (0 Trials) |
|
| para-toluenesulfonamide (PTS100) / Gongwin Biopharm (0 Trials) |
|
| paracetamol / Generic mfg. (384 Trials) |
|
| paracetamol suspension / Generic mfg. (0 Trials) |
|
| paracetamol Uniflash / Unither (0 Trials) |
|
| paracetamol/caffeine / Generic mfg. (0 Trials) |
|
| paracetamol/chlorpheniramine maleate/phenylepherine Hcl/caffeine / Generic mfg. (0 Trials) |
|
| Parcoten (paracetamol/codeine phosphate) / Neurelis (0 Trials) |
|
| pardoprunox (SLV-308) / AbbVie (1 Trials) |
|
| parentide (DD04107) / BCN Peptides, Lubrizol (0 Trials) |
|
| Pargevin (pargeverine) / AC Farma (0 Trials) |
|
| Pargevin Compound (pargeverine/lysine clonixinate) / AC Farma (0 Trials) |
|
| paricalcitol / Generic mfg. (30 Trials) |
|
| paridiprubart (EB07) / Edesa Biotech, Light Chain Biosci (0 Trials) |
|
| parimifasor (LYC-30937 EC) / BMS (0 Trials) |
|
| paritaprevir/ritonavir (ABT-450/r) / AbbVie (1 Trials) |
|
| Parkin activator / Vincere Biosci (0 Trials) |
|
| Parkinsan (budipine) / Lundbeck, Takeda (1 Trials) |
|
| Parkinson's disease therapeutic / Amgen (0 Trials) |
|
| Parkinson's disease therapeutic / AgoneX Biopharma (0 Trials) |
|
| Parkinson's disease therapeutic / C4X Discovery (0 Trials) |
|
| Parkinson's disease therapeutic / Canvax (0 Trials) |
|
| Parkinson's disease therapeutics / Servier, University of Barcelona (0 Trials) |
|
| Parkinson’s Disease cell therapy / Innervace (0 Trials) |
|
| Parmodia (pemafibrate) / Kowa (3 Trials) |
|
| parogrelil (INDI 702) / Taisho (0 Trials) |
|
| paroxetine / Generic mfg. (44 Trials) |
|
| paroxetine extended release / Generic mfg. (3 Trials) |
|
| paroxetine mesylate / Generic mfg. (0 Trials) |
|
| PARP inhibitors / Rocket Pharma (0 Trials) |
|
| PARP10 inhibitor / Ribon Therap (0 Trials) |
|
| PARP11 inhibitor / Ribon Therap (0 Trials) |
|
| PARP12 inhibitor / Ribon Therap (0 Trials) |
|
| PARP15 inhibitor / Ribon Therap (0 Trials) |
|
| PARP16 inhibitor / Ribon Therap (0 Trials) |
|
| PARP3 inhibitor / Ribon Therap (0 Trials) |
|
| PARP4 inhibitor / Ribon Therap (0 Trials) |
|
| PARP6 inhibitor / Ribon Therap (0 Trials) |
|
| PARP8 inhibitor / Ribon Therap (0 Trials) |
|
| PARP9 inhibitor / Ribon Therap (0 Trials) |
|
| Parsabiv (etelcalcetide) / Amgen (5 Trials) |
|
| parsaclisib (INCB50465) / Incyte (27 Trials) |
|
| parsatuzumab (RG7414) / Roche (0 Trials) |
|
| Partruvix (pamiparib) / EMD Serono, BeiGene (17 Trials) |
|
| ParvOryx (parvovirus H-1) / Oryx (0 Trials) |
|
| PAS-003 / Pasithea (0 Trials) |
|
| PAS-004 / Pasithea (1 Trials) |
|
| PAS-393 / Pascal Biosci (0 Trials) |
|
| PAS-403 / Pascal Biosci (0 Trials) |
|
| PAS-IL-1Ra / XL-protein (0 Trials) |
|
| pasotuxizumab (BAY2010112) / Amgen, Bayer (0 Trials) |
|
| pasylated uricase (HZN-007) / XL-protein, Amgen (0 Trials) |
|
| PAT-101 / Pasithea (0 Trials) |
|
| PAT-102 / Pasithea (0 Trials) |
|
| PAT-DX1 / Patrys (0 Trials) |
|
| PAT-LM1 / Patrys (0 Trials) |
|
| PAT-SC1 / Patrys (0 Trials) |
|
| PAT-SM6 / Patrys (0 Trials) |
|
| pateclizumab (RG7416) / Roche (0 Trials) |
|
| pathogen reduced SARS-CoV-2 convalescent plasma / Vanderbilt University Medical Center (0 Trials) |
|
| patidegib topical (IPI-926 topical) / Bridge Biotherap, LEO Pharma (0 Trials) |
|
| Patria (Recombinant NDV Vectored Vaccine for SARS-CoV-2) / National Autonomous University of Mexico, Avimex, Mexican Social Security Institute (0 Trials) |
|
| patritumab (U3-1287) / Amgen, Daiichi Sankyo (1 Trials) |
|
| patritumab deruxtecan (U3-1402) / Daiichi Sankyo, Merck (MSD) (8 Trials) |
|
| patupilone (EPO 906) / Novartis (3 Trials) |
|
| Pavacol-D (pholcodine) / Alliance (0 Trials) |
|
|